Examination of the ability of tumor necrosis factor-alpha (TNF) to activate
both the p44/42 and p38 MAP kinase cascades in fully differentiated 3T3-L1
adipocytes indicated a rapid MEK1/2-dependent activation of p44/42 MAP kin
ase. Use of the MEK1/2 inhibitor PD98059 indicated that this pathway at lea
st in part was responsible for nuclear localization of the transcription fa
ctor NF-kappa B. The stress/ cytokine-activated p38 NAP kinase was observed
to be constitutively active, and its phosphorylation (activation) status w
as not altered with TNF treatment. However, TNF treatment did result in act
ivation of the transcription factor, ATF-2, a primary downstream target of
p38 MAP kinase. Use of the p38 MAP kinase inhibitors SB202190 and SB202580
did not interfere with the ability of TNF to activate ATF-2, suggesting tha
t either the gamma isoform of p38 MAP kinase or a p38-independent pathway w
as utilized by TNF to increase the phosphorylated fraction of ATF-2, In pre
vious studies we had demonstrated the ability of TNF to suppress the transc
ription of the GLUT4 gene. Prevention of activation of either the p44/42 MA
P kinase pathway(PD98059) or the p38 MAP kinase pathway (SB202190 and SB202
580) indicated that these pathways did not control GLUT4 transcription. J.
Cell. Physiol. 179:58-66, 1999. (C) 1999 Wiley-Liss, Inc.